company background image
1681 logo

Consun Pharmaceutical Group SEHK:1681 Stock Report

Last Price

HK$5.77

Market Cap

HK$4.9b

7D

-10.5%

1Y

18.7%

Updated

13 Jun, 2024

Data

Company Financials +

Consun Pharmaceutical Group Limited

SEHK:1681 Stock Report

Market Cap: HK$4.9b

Consun Pharmaceutical Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Consun Pharmaceutical Group
Historical stock prices
Current Share PriceHK$5.77
52 Week HighHK$7.16
52 Week LowHK$4.31
Beta0.62
1 Month Change-19.41%
3 Month Change-2.20%
1 Year Change18.72%
3 Year Change13.36%
5 Year Change15.63%
Change since IPO17.76%

Recent News & Updates

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Jun 12
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

May 12
Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

Recent updates

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Jun 12
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

May 12
Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Jun 01
Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

May 04
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Apr 28
Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Apr 07
Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Aug 26
Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Apr 21
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Mar 17
Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

Feb 19
Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 29
How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Jan 08
Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Dec 18
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

Nov 18
Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

Shareholder Returns

1681HK PharmaceuticalsHK Market
7D-10.5%-2.1%-2.0%
1Y18.7%-4.6%-2.0%

Return vs Industry: 1681 exceeded the Hong Kong Pharmaceuticals industry which returned -4.6% over the past year.

Return vs Market: 1681 exceeded the Hong Kong Market which returned -2% over the past year.

Price Volatility

Is 1681's price volatile compared to industry and market?
1681 volatility
1681 Average Weekly Movement5.8%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement7.2%
10% most volatile stocks in HK Market15.4%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 1681 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1681's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19973,127Meng Anwww.chinaconsun.com

Consun Pharmaceutical Group Limited researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China. It operates in two segments, Consun Pharmaceutical and Yulin Pharmaceutical. The company offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles for proteinuria; TCM to treat diabetic kidney disease; Gadopentetate Dimeglumine injections for nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; Iopamidol injections for neuroradiology, angiography, and urography; and ultrasonic microbubble contrast agent products.

Consun Pharmaceutical Group Limited Fundamentals Summary

How do Consun Pharmaceutical Group's earnings and revenue compare to its market cap?
1681 fundamental statistics
Market capHK$4.87b
Earnings (TTM)HK$844.91m
Revenue (TTM)HK$2.79b

5.6x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1681 income statement (TTM)
RevenueCN¥2.59b
Cost of RevenueCN¥668.44m
Gross ProfitCN¥1.92b
Other ExpensesCN¥1.14b
EarningsCN¥784.53m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.95
Gross Margin74.19%
Net Profit Margin30.29%
Debt/Equity Ratio12.8%

How did 1681 perform over the long term?

See historical performance and comparison

Dividends

10.3%

Current Dividend Yield

41%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.